Back to Treatments

Treatment

Cytarabine + Daunorubicin ("7+3" Induction Chemotherapy)

1
Conditions
22
Trials
50K
Participants
25%
Average Safety

Condition Evidence

Acute myeloid leukemia

22 trials · 50K participants

85% effectiveness · 25% safety
Cytarabine + Daunorubicin ("7+3" Induction Chemotherapy) | DFDA